美股A股
StockGist
Back
8-K2026-02-19· grok-4-1-fast-non-reasoning

MDGL · Madrigal Pharmaceuticals, Inc.

0001628280-26-009476

SEC filing

Summary

Madrigal Pharmaceuticals, Inc. issued a press release on February 19, 2026, announcing results of operations and financial condition. The filing includes Exhibit 99.1, the press release dated February 19, 2026.

Key takeaways